Current
AOK gegen vorzeitige Verlängerung des Innovationsfonds
Der AOK-Bundesverband spricht sich gegen eine vorzeitige Verlängerung des Innovationsfonds aus. "Erst müssen die Ergebnisse der gesetzlich vorgesehenen Evaluation des Förderkonzepts vorliegen, dann kann auch verantwortungsvoll über eine Fortsetzung entschieden werden", fordert der Vorsitzende ...
14.11.2017
CGM is now starting to connect practices to the telematics infrastructure
CompuGroup Medical Deutschland AG (CGM) erfüllt als erster Anbieter alle notwendigen Voraussetzungen und bindet ab sofort Praxen, beginnend mit Zahnarztpraxen, an die Telematikinfrastruktur an. Alle Komponenten und Dienste, die für eine TI-Installation benötigt werden, sind von der gematik ...
13.11.2017
BMG fördert Förderung der Cochrane Deutschland Stiftung
Ab sofort fördert das Bundesministerium für Gesundheit die deutsche Vertretung der Cochrane Collaboration in Freiburg, die Cochrane Deutschland Stiftung, mit jährlich bis zu einer Million Euro. Am 9. November verschickte das Bundesverwaltungsamt den offiziellen Förderbescheid an die Stiftung.
10.11.2017
Optimedis establishes Digital & Health Innovation Centre
Optimedis AG aims to facilitate access to healthcare for promising innovations. It has established a Digital & Health Innovation Centre that evaluates innovations such as health apps, online interventions, and disease-specific programs...
10.11.2017
DAlzG Research Funding 2018 Announced
In 2018, the German Alzheimer Society (DAlzG) is awarding a maximum of €200,000 to support research projects whose results demonstrably contribute to improving the situation of people with dementia and their relatives.
06.11.2017
Further funding decisions for healthcare research and evaluation of selective contracts
The Innovation Committee of the Federal Joint Committee (G-BA) made further decisions on November 2nd in Berlin regarding the funding of projects for healthcare research and the evaluation of selective contracts. Within the set deadline, 164 project proposals were received, which...
06.11.2017
High potential for improvement for the M-RSA
The first of two special reports, prepared by the voluntary Scientific Advisory Board of the Federal Insurance Office (BVA) as a basis for a possible further development of the morbidity-based risk structure compensation scheme (M-RSA), was presented at a press conference at the BVA in Bonn...
19.10.2017
Servier and Novartis are cooperating
The pharmaceutical companies Servier Germany and Novartis Pharma will enter into a sales cooperation in Germany starting November 1, 2017. The core of the agreement is the nationwide co-promotion of sacubitril/valsartan ("Entresto"), an angiotensin receptor-neprilysin inhibitor...
18.10.2017
A significant proportion of people with cancer are underserved or mistreated in terms of pain management. This is evidenced by the results of an online survey conducted by the German Society for Pain Medicine (DGS) and the German Pain League (DSL) (www.Praxisumfrage-Tumorschmerz.de) at ...